Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Time's Up...
View:
Post by Quentin30 on Jun 25, 2024 2:45pm

Time's Up...

So, by now FDA will have responded to ONCY's Type C Meeting questions. Unlikely that they have exceeded the 75 day goal date.

So what does the absence of an announcement from ONCY portend..?  Well, if they were trying to get agreement on a biomarker (from FDA) to be used as a surrogate end-point, then it means Notable's spiel about Accelerated Approval is just talk.. it WON'T happen..

And how strange that Matt had a relapse just in time not to have to face the music... Oh btw, get well soon Matt.

So...  we've lost our Business Development lead, and now the CEO (Kirk Crook looks set to remain), but since we change CMO's every few years, I wonder if even Professor Heineken will be next to make a move...

 so, the ball is in your court now Mr Pisano... please do something, just anything with it...

hmmmm.. no news is bad news eh, until it is...
Comment by Noteable on Jun 25, 2024 3:23pm
A new VP of Business Development for ONCY was hired in May. Unfortunately you have been out of touch with everything ONCY.
Comment by Noteable on Jun 25, 2024 3:29pm
Furthermore Quentin30 you claim to have consolidated your holdings of ONCY to 1/4 of your former position, so why worry about ONCY now.
Comment by Quentin30 on Jun 25, 2024 6:14pm
Yup, I downsized my position. Since Matt hadn't mentioned Accelerated Approval wrt to mBC, and since they were only planning to release full results later in the year, I reasoned that a value inflection point would still not come until Q3 at the earliest, so this was just dead money. But each to their own... I might miss the big rise, so I'll only get a quarter of what I once might have.. ...more  
Comment by Journeytc on Jun 25, 2024 6:43pm
Quentin i think understand your logic but have a different take.   Knocking off critical path tasks matters most. Critical path items define when paleo goes to market and when a take over is most likely.  Announcement of mBC oversll survival  results is not on that list. Critical path items include: Conclusion of type c meeting Submissiom of phase 3 documentation Approval of ...more  
Comment by Noteable on Jun 25, 2024 6:46pm
Yes Quentin30....  to each his/her own. So why the consistent dissing? Afraid that you're wrong perhaps?
Comment by Peladawn on Jun 26, 2024 10:28am
This post has been removed in accordance with Community Policy
Comment by Srxman2001 on Jun 26, 2024 10:35am
Looking for excuses already when dumpster fails you again?
Comment by Peladawn on Jun 26, 2024 10:41am
Excuses?.....instead of your spin, why not just admit that if Trump had to hide away for a week, you'd be the one with dozens of excuses, and you'd be ripping him apart.....as I said your hypocracy knows no bounds.
Comment by Peladawn on Jun 26, 2024 11:05am
Why don't you go and talk about failures to the families of Rachel Morin, Joselyn Nungary, Laken Riley, and all the other young girls and women who have be brutally raped and murdered by violent criminals, foolishly allowed into the country by Biden's failure from day one on the border....talk to them about "Trumps" supposed "failures".
Comment by Peladawn on Jun 26, 2024 11:50am
And speaking of failures, I wonder how many more Isis fighters are in the US right now, (given the 1.5 MILLION known "gotaways" already reported in the last 3 years of the Biden open border policy) planning terrorist attacks against even more innocent Americans .....perhaps, anyone who is complacent with this policy, and thinks it's no big deal, well perhaps your children and ...more  
Comment by Buckhenry on Jun 26, 2024 12:59pm
Guess yall had to resort to politics bashing since this POS stock is down the tubes. 
Comment by Peladawn on Jun 26, 2024 1:09pm
Well Bucky, unlike this company, and your disingenuous babbling about it, there's a lot to bash about in politics.
Comment by itntdf on Jun 26, 2024 11:49am
will be interesting to see if cheeto will walk out onstage and settle in behind his podium or if he will be in place before the cameras roll.  imagine it would be difficult walking with a truckers catheter and a bag strapped to your leg not to mention the three layers of depends he will be wearing in case he loses his mess.   alternatively, he may forego hydration for a number of ...more  
Comment by ENEMENEMYNEMO on Jun 25, 2024 4:04pm
Maybe Matt drank the Kool-Aid too???
Comment by Noteable on Jun 25, 2024 4:09pm
Or maybe the unpasteurized milk you shared with him?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities